心脏机械灌注技术的研究现状

刘金平; 王伟

doi:10.3969/j.issn.1674-7445.2023.04.002

心脏机械灌注技术的研究现状

doi: 10.3969/j.issn.1674-7445.2023.04.002

刘金平^, ,,
王伟

430071 武汉，武汉大学中南医院心血管外科心脏大血管外科微创诊疗湖北省工程研究中心武汉市结构性心脏病微创诊疗临床医学研究中心

基金项目:

国家自然科学基金面上项目 82170505

详细信息

作者简介:

通讯作者:
刘金平（ORCID：0000-0002-9384-4880），Email：liujinping@whu.edu.cn

中图分类号: R617, R552
计量
- 文章访问数: 280
- HTML全文浏览量: 60
- PDF下载量: 48
- 被引次数: 0
出版历程
- 收稿日期: 2023-02-03
- 网络出版日期: 2023-07-13
- 刊出日期: 2023-07-15

Research status of machine perfusion of heart

Liu Jinping^{,
,},
Wang Wei

Department of Cardiovascular Surgery, Zhongnan Hospital of Wuhan University, Hubei Provincial Engineering Research Center of Minimally Invasive Cardiovascular Surgery, Wuhan Clinical Research Center for Minimally Invasive Treatment of Structural Heart Disease, Wuhan 430071, China

More Information

Corresponding author: Liu Jinping, Email: liujinping@whu.edu.cn

摘要

摘要: 高质量的供心是移植成功的先决条件和根本保障，合理的供心保存技术对提升供心质量、改善心脏移植预后具有关键作用。静态冷保存（SCS）是目前移植心脏的标准保存技术，但该技术易造成供心严重的冷缺血损伤，且保存过程中无法评估心脏功能。机械灌注技术作为当前器官保存的重要新型技术，比SCS更符合生理状态，能够在器官保存过程中清除代谢废物、提供代谢需求的基本物质，一定程度延长保存时间、提升保存效果；也能有效评估器官功能，改善心脏移植预后；同时还能修复器官损伤，显著优化器官质量，提高供器官利用率。本文就心脏机械灌注技术的研究现状展开综述。
- 心脏移植 /
- 供心保存 /
- 缺血-再灌注损伤 /
- 静态冷保存 /
- 机械灌注 /
- 扩大标准供者 /
- 心脏死亡器官捐献(DCD) /
- 脑死亡器官捐献(DBD)
Abstract: High-quality donor heart is the prerequisite and fundamental guarantee for successful heart transplantation. Reasonable donor heart preservation technique plays a key role in improving the quality of donor heart and the prognosis of heart transplantation. Static cold storage (SCS) is currently the standard preservation technique for cardiac allograft. However, it is prone to cause severe cold ischemia injury to the donor heart, and it is impossible to evaluate heart function during SCS. As an important emerging technique of organ preservation, machine perfusion better matches with physiological conditions compared with SCS, which may remove metabolic wastes and provide basic substances for metabolic needs during organ preservation, prolong the preservation time and improve the preservation effect to a certain extent. Besides, it may also effectively evaluate organ function and improve clinical prognosis of heart transplantation. Meantime, it can also repair organ damage, significantly optimize organ quality and improve the utilization rate of donor organs. In this article, research status of machine perfusion of donor heart was reviewed.
- Heart transplantation /
- Donor heart preservation /
- Ischemia-reperfusion injury /
- Static cold storage /
- Machine perfusion /
- Expanded criteria donor /
- Donation after cardiac death (DCD) /
- Donation after brain death (DBD)

HTML全文

下载: 全尺寸图片幻灯片

参考文献(38)

[1]	FAN YYK, WONG KL, HO KLC, et al. Trends in contemporary advanced heart failure management: an in-depth review over 30 years of heart transplant service in Hong Kong[J]. Korean J Transplant, 2022, 36(4): 267-277. DOI: 10.4285/kjt.22.0038.
[2]	CHEW HC, MACDONALD PS, DHITAL KK. The donor heart and organ perfusion technology[J]. J Thorac Dis, 2019, 11(Suppl 6): S938-S945. DOI: 10.21037/jtd.2019.02.59.
[3]	KVIETKAUSKAS M, LEBER B, STRUPAS K, et al. Machine perfusion of extended criteria donor organs: immunological aspects[J]. Front Immunol, 2020, 11: 192. DOI: 10.3389/fimmu.2020.00192.
[4]	KHUSH KK, POTENA L, CHERIKH WS, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult heart transplantation report-2020; focus on deceased donor characteristics[J]. J Heart Lung Transplant, 2020, 39(10): 1003-1015. DOI: 10.1016/j.healun.2020.07.010.
[5]	HESS NR, ZIEGLER LA, KACZOROWSKI DJ. Heart donation and preservation: historical perspectives, current technologies, and future directions[J]. J Clin Med, 2022, 11(19): 5762. DOI: 10.3390/jcm11195762.
[6]	QIN G, SU Y, SJÖBERG T, et al. Oxygen consumption of the aerobically-perfused cardioplegic donor heart at different temperatures[J]. Ann Transplant, 2018, 23: 268-273. DOI: 10.12659/AOT.907753.
[7]	中国肝移植注册中心, 国家肝脏移植质控中心, 国家人体捐献器官获取质控中心, 等. 中国移植器官保护专家共识(2022版)[J]. 器官移植, 2022, 13(2): 144-160. DOI: 10.3969/j.issn.1674-7445.2022.02.002. China Liver Transplant Registry, National Center for Healthcare Quality Management in Liver Transplant, National Quality Control Center for Human Donated Organ Procurement, et al. Chinese expert consensus on organ protection of transplantation (2022 edition)[J]. Organ Transplant, 2022, 13(2): 144-160. DOI: 10.3969/j.issn.1674-7445.2022.02.002.
[8]	XU J, BUCHWALD JE, MARTINS PN. Review of current machine perfusion therapeutics for organ preservation[J]. Transplantation, 2020, 104(9): 1792-1803. DOI: 10.1097/TP.0000000000003295.
[9]	RESCH T, CARDINI B, OBERHUBER R, et al. Transplanting marginal organs in the era of modern machine perfusion and advanced organ monitoring[J]. Front Immunol, 2020, 11: 631. DOI: 10.3389/fimmu.2020.00631.
[10]	WANG L, MACGOWAN GA, ALI S, et al. Ex situ heart perfusion: the past, the present, and the future[J]. J Heart Lung Transplant, 2021, 40(1): 69-86. DOI: 10.1016/j.healun.2020.10.004.
[11]	PORTILLO DJ, GONZALEZ J, VILLARREAL C, et al. Development and characterization of a nonelectronic versatile oxygenating perfusion system for tissue preservation[J]. Ann Biomed Eng, 2022, 50(8): 978-990. DOI: 10.1007/s10439-022-02977-2.
[12]	SAEMANN L, KOHL M, VERES G, et al. Prediction model for contractile function of circulatory death donor hearts based on microvascular flow shifts during ex situ hypothermic cardioplegic machine perfusion[J]. J Am Heart Assoc, 2022, 11(23): e027146. DOI: 10.1161/JAHA.122.027146.
[13]	BONA M, WYSS RK, ARNOLD M, et al. Cardiac graft assessment in the era of machine perfusion: current and future biomarkers[J]. J Am Heart Assoc, 2021, 10(4): e018966. DOI: 10.1161/JAHA.120.018966.
[14]	SAEMANN L, KORKMAZ-ICÖZ S, HOORN F, et al. Reconditioning of circulatory death hearts by ex-vivo machine perfusion with a novel HTK-N preservation solution[J]. J Heart Lung Transplant, 2021, 40(10): 1135-1144. DOI: 10.1016/j.healun.2021.07.009.
[15]	VAN CAENEGEM O, BEAULOYE C, BERTRAND L, et al. Hypothermic continuous machine perfusion enables preservation of energy charge and functional recovery of heart grafts in an ex vivo model of donation following circulatory death[J]. Eur J Cardiothorac Surg, 2016, 49(5): 1348-1353. DOI: 10.1093/ejcts/ezv409.
[16]	BRÜGGENWIRTH IMA, VAN LEEUWEN OB, DE VRIES Y, et al. Extended hypothermic oxygenated machine perfusion enables ex situ preservation of porcine livers for up to 24 hours[J]. JHEP Rep, 2020, 2(2): 100092. DOI: 10.1016/j.jhepr.2020.100092.
[17]	PANAYOTOVA GG, ROSADO J, PATERNO F, et al. Novel oxygenation technique for hypothermic machine perfusion of liver grafts: validation in porcine donation after cardiac death (DCD) liver model[J]. Am J Surg, 2020, 220(5): 1270-1277. DOI: 10.1016/j.amjsurg.2020.06.072.
[18]	DONDOSSOLA D, RAVAIOLI M, LONATI C, et al. The role of ex situ hypothermic oxygenated machine perfusion and cold preservation time in extended criteria donation after circulatory death and donation after brain death[J]. Liver Transpl, 2021, 27(8): 1130-1143. DOI: 10.1002/lt.26067.
[19]	WYSS RK, MÉNDEZ CARMONA N, ARNOLD M, et al. Hypothermic, oxygenated perfusion (HOPE) provides cardioprotection via succinate oxidation prior to normothermic perfusion in a rat model of donation after circulatory death (DCD)[J]. Am J Transplant, 2021, 21(3): 1003-1011. DOI: 10.1111/ajt.16258.
[20]	WEI J, CHEN S, XUE S, et al. Blockade of inflammation and apoptosis pathways by siRNA prolongs cold preservation time and protects donor hearts in a porcine model[J]. Mol Ther Nucleic Acids, 2017, 9: 428-439. DOI: 10.1016/j.omtn.2017.10.020.
[21]	KORKMAZ-ICÖZ S, LI S, HÜTTNER R, et al. Hypothermic perfusion of donor heart with a preservation solution supplemented by mesenchymal stem cells[J]. J Heart Lung Transplant, 2019, 38(3): 315-326. DOI: 10.1016/j.healun.2018.12.003.
[22]	LI Y, ZENG Q, LIU G, et al. Development and evaluation of heartbeat: a machine perfusion heart preservation system[J]. Artif Organs, 2017, 41(11): E240-E250. DOI: 10.1111/aor.12867.
[23]	RAGALIE WS, ARDEHALI A. Current status of normothermic ex-vivo perfusion of cardiac allografts[J]. Curr Opin Organ Transplant, 2020, 25(3): 237-240. DOI: 10.1097/MOT.0000000000000759.
[24]	ROJAS SV, AVSAR M, IUS F, et al. Ex-vivo preservation with the organ care system in high risk heart transplantation[J]. Life (Basel), 2022, 12(2): 247. DOI: 10.3390/life12020247.
[25]	PINNELAS R, KOBASHIGAWA JA. Ex vivo normothermic perfusion in heart transplantation: a review of the TransMedics^® Organ Care System[J]. Future Cardiol, 2022, 18(1): 5-15. DOI: 10.2217/fca-2021-0030.
[26]	LANGMUUR SJJ, AMESZ JH, VEEN KM, et al. Normothermic ex situ heart perfusion with the Organ Care System for cardiac transplantation: a meta-analysis[J]. Transplantation, 2022, 106(9): 1745-1753. DOI: 10.1097/TP.0000000000004167.
[27]	DEFILIPPIS EM, KHUSH KK, FARR MA, et al. Evolving characteristics of heart transplantation donors and recipients: JACC focus seminar[J]. J Am Coll Cardiol, 2022, 79(11): 1108-1123. DOI: 10.1016/j.jacc.2021.11.064.
[28]	MEDRESSOVA A, FAIZOV L, KUANYSHBEK A, et al. Successful heart transplantation after 17 h ex vivo time using the Organ Care System-3 years follow-up[J]. J Card Surg, 2021, 36(7): 2592-2595. DOI: 10.1111/jocs.15519.
[29]	JOSHI Y, SCHEUER S, CHEW H, et al. Heart transplantation from DCD donors in Australia: lessons learned from the first 74 cases[J]. Transplantation, 2023, 107(2): 361-371. DOI: 10.1097/TP.0000000000004294.
[30]	MADAN S, SAEED O, FOREST SJ, et al. Feasibility and potential impact of heart transplantation from adult donors after circulatory death[J]. J Am Coll Cardiol, 2022, 79(2): 148-162. DOI: 10.1016/j.jacc.2021.10.042.
[31]	CHEW HC, IYER A, CONNELLAN M, et al. Outcomes of donation after circulatory death heart transplantation in Australia[J]. J Am Coll Cardiol, 2019, 73(12): 1447-1459. DOI: 10.1016/j.jacc.2018.12.067.
[32]	GIWA S, LEWIS JK, ALVAREZ L, et al. The promise of organ and tissue preservation to transform medicine[J]. Nat Biotechnol, 2017, 35(6): 530-542. DOI: 10.1038/nbt.3889.
[33]	RIBEIRO RVP, ALVAREZ JS, YU F, et al. Comparing donor heart assessment strategies during ex situ heart perfusion to better estimate posttransplant cardiac function[J]. Transplantation, 2020, 104(9): 1890-1898. DOI: 10.1097/TP.0000000000003374.
[34]	OLKOWICZ M, RIBEIRO RVP, YU F, et al. Dynamic metabolic changes during prolonged ex situ heart perfusion are associated with myocardial functional decline[J]. Front Immunol, 2022, 13: 859506. DOI: 10.3389/fimmu.2022.859506.
[35]	TATUM R, BRIASOULIS A, TCHANTCHALEISHVILI V, et al. Evaluation of donor heart for transplantation[J]. Heart Fail Rev, 2022, 27(5): 1819-1827. DOI: 10.1007/s10741-021-10178-7.
[36]	游可为, 刘嘉馨, 王文刚, 等. 含戊二醛聚合牛源HBOC的新型器官保存液对延长大鼠离体心脏保存时间的研究[J]. 中国生物医学工程学报, 2023, 42(2): 252-256. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSWY202302014.htm YOU KW, LIU JX, WANG WG, et al. Preservation duration of ex-vivo rat heart using a novel organ preservation solution containing glutaraldehyde polymerized bovine hemoglobin[J]. Chin J Biomed Eng, 2023, 42(2): 252-256. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSWY202302014.htm
[37]	张帅, 郑珊珊, 宋武, 等. 冷缺血时间及供者年龄对心脏移植受者预后的影响: 单中心临床研究[J]. 中国循环杂志, 2022, 37(1): 45-51. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXH202201005.htm ZHANG S, ZHENG SS, SONG W, et al. Impact of cold ischemia time and donor age on the prognosis of heart transplantation: a single-center clinical study[J]. Chin Circ J, 2022, 37(1): 45-51. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXH202201005.htm
[38]	游可为, 刘嘉馨, 王相朦, 等. 血红蛋白氧载体在器官移植中的研究现状和应用前景[J]. 中国输血杂志, 2022, 35(8): 810-813. DOI: 10.13303/j.cjbt.issn.1004-549x.2022.08.007. YOU KW, LIU JX, WANG XM, et al. Research status and application prospect of hemoglobin-based oxygen carriers in organ transplantation[J]. Chin J Blood Transfus, 2022, 35(8): 810-813. DOI: 10.13303/j.cjbt.issn.1004-549x.2022.08.007.